The Leukemia & Lymphoma Societyinc

Washington, DC ·EIN 13-5644916 ·Grant funding profile from IRS 990 filings

The Leukemia & Lymphoma Societyinc also makes grants — see its funder profile →

$10.5M received 175 funders 200 grants · 2024–2025

Who funds The Leukemia & Lymphoma Societyinc?

The Leukemia & Lymphoma Societyinc is funded by 175 grantmakers, led by Vanguard Charitable Endowment Program ($2.0M), Institute for Follicular Lymphoma ($1.2M), Pledgeling Foundation ($748K). In total, IRS Form 990 filings record $10.5M in grants to The Leukemia & Lymphoma Societyinc between 2024–2025.

What grants has The Leukemia & Lymphoma Societyinc received?

Individual grants from IRS Form 990 filings, newest first

YearFunderPurposeAmount
2025Combined Health Agencies DriveTO CURE LEUKEMIA, NON-HODGKIN'S LYMPHOMA, HODGKIN'S LYMPHOMA AND MYELOMA AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND FAMILIES$51,949
2025The Avery Goldberg Family FoundationincGENERAL PURPOSE$50,000
2025The Elias Genevieve and Georgianna AtolSUPPORT BLOOD CANCER RESEARCH$25,000
2025Peggy & Margaret Dupaquier Charitable TrustGENERAL SUPPORT$22,842
2025United Way Miami IncGENERAL SUPPORT$19,008
2025Ergon Foundation IncGENERAL SUPPORT$10,000
2025The Ohana FoundationTO FUND BLOOD CANCER RESEARCH, PROVIDE PATIENT SUPPORT AND ADVOCACY, SUPPORT PUBLIC AND PROFESSIONAL EDUCATION$10,000
2025North Carolina Community FoundationTO SUPPORT THE ORGANIZATION'S STATED MISSION$10,000
2025Herman & Seena Lubcher CharitableOPERATIONS$7,400
2025The Savannah Community FoundationFINANCIAL SUPPORT$5,200
2025The Savannah Community FoundationFINANCIAL SUPPORT$5,200
2025Jesy FoundationDONATION$5,000
2025The Beck Foundation IncRESEARCH$5,000
2025The Rosenfeld Rumford Steckler FamilyEDUCATIONAL & TRAINING PROGRAM$2,000
2025Theresa M Donnermeyer TrustGENERAL SUPPORT$1,175
2025Richard Ann John & James SolomonCHARITABLE$1,000
2025The Zachs Family Foundation IncGeneral Use$500
2025John E Fetzer Institute IncGENERAL OPERATING SUPPORT$200
2025The White Companies Charitable TrustGENERAL SUPPORT$150
2025The Joe & Sandy Samberg Foundation IncCHARITABLE$100
2025Macjets Evans Family FoundationCHARITABLE PROGRAMS$100
2024Vanguard Charitable Endowment ProgramFOR RECIPIENT'S EXEMPT PURPOSE$1,966,015
2024Institute for Follicular LymphomaFOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA$1,211,957
2024Pledgeling FoundationGENERAL$748,109
2024Gateway for Cancer ResearchCANCER RESEARCH$500,067
2024Laura and John Arnold FoundationTO ADDRESS THE IMPACT OF HIGH PROVIDER PRICES ON PATIENTS AND THEIR FAMILIES.$285,650
2024University of MiamiGENERAL SUPPORT$285,000
2024Fm Kirby Foundation IncFOR: SUPPORT OF THE DARE TO DREAM PROJECT$250,000
2024Norman E Alexander Family S FoundationMEDICAL PURPOSES$250,000
2024The William G Pomeroy FoundationYEAR END GIFT$250,000

Showing 30 most recent of 200 recorded grants.

Frequently Asked Questions

Who funds The Leukemia & Lymphoma Societyinc?

The Leukemia & Lymphoma Societyinc is funded by 175 grantmakers, led by Vanguard Charitable Endowment Program ($2.0M), Institute for Follicular Lymphoma ($1.2M), Pledgeling Foundation ($748K). In total, IRS Form 990 filings record $10.5M in grants to The Leukemia & Lymphoma Societyinc between 2024–2025.

Who is The Leukemia & Lymphoma Societyinc's largest funder?

Vanguard Charitable Endowment Program is the largest recorded funder of The Leukemia & Lymphoma Societyinc, with $2.0M across 1 grant (2024).

How much grant funding has The Leukemia & Lymphoma Societyinc received?

IRS 990 filings record $10.5M in grants to The Leukemia & Lymphoma Societyinc across 200 grants from 175 funders between 2024–2025. Filings are published on a delay, so recent grants may not appear yet.

Looking for funders like The Leukemia & Lymphoma Societyinc's?

Grantable's AI matches your organization against 200,000+ grantmakers — including every funder on this page — using their real giving history.

Grant data is drawn from IRS Form 990 filings via Grantable's GrantGraph™. Filings are published on a delay; recent grants may not appear yet.